Radiation plus Chemotherapy in Low-Grade Glioma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A Review.JAMA oncology · 2025
   Review
2. Determinants of long-term survival in patients with IDH-mutant gliomas.Journal of neuro-oncology · 2024
   Article
3. Patterns of intersectional tumor volumes in T2-weighted MRI and [Scientific reports · 2024
   Observational
4. An In Vitro Model of Glioma Development.Genes · 2023
   Article
5. Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.Journal of neuro-oncology · 2022
   Article
6. Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.Neuro-oncology · 2022
   Article
7. The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study.Neuro-oncology · 2022
   Article
8. PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression.Journal of neuro-oncology · 2021
   Article
9. Establishment and Preliminary Characterization of Three Astrocytic Cells Lines Obtained from Primary Rat Astrocytes by Sub-Cloning.Genes · 2020
   Article
10. Rate of change in maximumJournal of neuro-oncology · 2020
    Article
11. The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas.Science translational medicine · 2020
    Article
12. Therapeutic Interventions in Adult Low-Grade Gliomas.Journal of clinical neurology (Seoul, Korea) · 2019
    Review
13. Patterns of radiological response to procarbazine and CCNU polychemotherapy in patients with oligodendroglioma.Neuro-oncology advances
    Article
14. Mapping glioma's impact on cognition: Insights from macrostructure, microstructure, and beyond.Neuro-oncology advances
    Article

Corrections and comments

• Comment on
  Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.2016
• Comment on
  Radiation plus Chemotherapy in Low-Grade Glioma.2016
• Comment on
  Radiation plus Chemotherapy in Low-Grade Glioma.2016

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as